Skip to main content
NCBI home page
Genitourinary Medicine logoLink to Genitourinary Medicine
. 1993 Dec;69(6):457–459. doi: 10.1136/sti.69.6.457

The effect of suppressive oral acyclovir on the psychological morbidity associated with recurrent genital herpes.

O Carney 1, E Ross 1, G Ikkos 1, A Mindel 1
PMCID: PMC1195151  PMID: 8282300

Abstract

OBJECTIVES--To assess the psychological impact of recurrent genital herpes and to determine if longterm acyclovir has any impact on this morbidity. SETTING AND SUBJECTS--Patients with frequently recurring genital herpes attending a department of genitourinary medicine who were considered suitable for longterm acyclovir. METHODS--Patients completed an 80 item, self-administered psychological questionnaire before starting acyclovir and every three months for one year. Treatment was then stopped and three months later a further questionnaire was completed. The questionnaire consisted of the General Health Questionnaire (GHQ); the Hospital Anxiety and Depression Questionnaire (HADQ); Illness Attitude Scales and Illness Concern. Data were analysed by McNemar's test for changes in proportions and by Wilcoxon's test for changes in scores. RESULTS--102 patients were recruited: 55 men, and 47 women. Eighty two (80%) patients completed three months treatment, 75 (74%) six months, 64 (63%) nine months and 61 (60%) a year. Fifty (49%) of the original 102 patients completed the three months post treatment follow up. At first visit 63% (64/102) were designated as GHQ "cases". Within three months this decreased to 26% (21/82). McNemar's test showed that 67% (34/51) of the patients who were initially classified as GHQ "cases" became "noncases" after three months (p < 0.0001). There was a significant decrease in the proportion of HAD anxiety cases from visit one to visit two (p < 0.0001) and a decrease in illness concern scores from visit one to visit two (p < 0.0001). All these decreases were maintained throughout the years treatment with acyclovir. CONCLUSIONS--There is a substantial morbidity associated with frequently recurring genital herpes. However, acyclovir suppression significantly reduces illness concern and anxiety and is a useful addition to the treatment of this infection.

Full text

PDF
457

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alder M. W., Mindel A. Genital herpes: hype or hope? Br Med J (Clin Res Ed) 1983 Jun 4;286(6380):1767–1768. doi: 10.1136/bmj.286.6380.1767. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aral S. O., Vanderplate C., Magder L. Recurrent genital herpes: what helps adjustment? Sex Transm Dis. 1988 Jul-Sep;15(3):164–166. doi: 10.1097/00007435-198807000-00011. [DOI] [PubMed] [Google Scholar]
  3. Barczak P., Kane N., Andrews S., Congdon A. M., Clay J. C., Betts T. Patterns of psychiatric morbidity in a genito-urinary clinic. A validation of the Hospital Anxiety Depression scale (HAD). Br J Psychiatry. 1988 May;152:698–700. doi: 10.1192/bjp.152.5.698. [DOI] [PubMed] [Google Scholar]
  4. Beaman K., Luzzatto P. Psychological approaches to the treatment of skin diseases. Nursing (Lond) 1988 Aug-Sep;3(29):1061–1063. [PubMed] [Google Scholar]
  5. Catalan J., Bradley M., Gallwey J., Hawton K. Sexual dysfunction and psychiatric morbidity in patients attending a clinic for sexually transmitted diseases. Br J Psychiatry. 1981 Apr;138:292–296. doi: 10.1192/bjp.138.4.292. [DOI] [PubMed] [Google Scholar]
  6. Chenitz W. C., Swanson J. M. Counseling clients with genital herpes. J Psychosoc Nurs Ment Health Serv. 1989 Sep;27(9):11–17. doi: 10.3928/0279-3695-19890901-09. [DOI] [PubMed] [Google Scholar]
  7. Cotterill J. A. Psychiatry and the skin. Br J Hosp Med. 1989 Nov;42(5):401–404. [PubMed] [Google Scholar]
  8. Goldmeier D., Johnson A., Byrne M., Barton S. Psychosocial implications of recurrent genital herpes simplex virus infection. Genitourin Med. 1988 Oct;64(5):327–330. doi: 10.1136/sti.64.5.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Kinghorn G. R., Jeavons M., Rowland M., Abeywickreme I., Barton I. G., Potter C. W., Hickmott E. A. Acyclovir prophylaxis of recurrent genital herpes: randomised placebo controlled crossover study. Genitourin Med. 1985 Dec;61(6):387–390. doi: 10.1136/sti.61.6.387. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mindel A., Faherty A., Carney O., Patou G., Freris M., Williams P. Dosage and safety of long-term suppressive acyclovir therapy for recurrent genital herpes. Lancet. 1988 Apr 23;1(8591):926–928. doi: 10.1016/s0140-6736(88)91725-4. [DOI] [PubMed] [Google Scholar]
  11. Pedder J. R., Goldberg D. P. A survey by questionnaire of psychiatric disturbance in patients attending a venereal diseases clinic. Br J Vener Dis. 1970 Feb;46(1):58–61. doi: 10.1136/sti.46.1.58. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Rand K. H., Hoon E. F., Massey J. K., Johnson J. H. Daily stress and recurrence of genital herpes simplex. Arch Intern Med. 1990 Sep;150(9):1889–1893. [PubMed] [Google Scholar]
  13. Swanson J. M., Chenitz W. C. Psychosocial aspects of genital herpes: a review of the literature. Public Health Nurs. 1990 Jun;7(2):96–104. doi: 10.1111/j.1525-1446.1990.tb00618.x. [DOI] [PubMed] [Google Scholar]
  14. VanderPlate C., Aral S. O. Psychosocial aspects of genital herpes virus infection. Health Psychol. 1987;6(1):57–72. doi: 10.1037//0278-6133.6.1.57. [DOI] [PubMed] [Google Scholar]
  15. Wessely S. C., Lewis G. H. The classification of psychiatric morbidity in attenders at a dermatology clinic. Br J Psychiatry. 1989 Nov;155:686–691. doi: 10.1192/s0007125000018201. [DOI] [PubMed] [Google Scholar]
  16. Yohman J. R., Schaeffer K. W., Parsons O. A. Cognitive training in alcoholic men. J Consult Clin Psychol. 1988 Feb;56(1):67–72. doi: 10.1037//0022-006x.56.1.67. [DOI] [PubMed] [Google Scholar]

Articles from Genitourinary Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES